Receiving a cancer diagnosis can drastically change a person’s life, often leaving them feeling lost and frightened. Victor Gonzalez, a senior director at The Lymphoma Research Foundation, knows this reality all too well. His personal encounters with blood cancer—watching his mother struggle against aggressive stomach cancer and facing his own diagnosis of Barrett’s esophagus—have given him invaluable insights into the emotional turmoil that often accompanies such news.
Throughout his career, Gonzalez has worked closely with patients diagnosed with lymphoma and leukemia, particularly those dealing with chronic lymphocytic leukemia (CLL). He has observed the myriad of emotional responses that can follow a cancer diagnosis, including shock and paralysis. However, he also stresses the importance of seeking knowledge and finding encouragement in the stories of others who have faced similar challenges.
Every CLL journey is distinct, yet Gonzalez points out certain key moments that can help patients feel a sense of progress and resilience throughout their treatment. He urges patients to concentrate on meaningful experiences in their lives and to explore new paths for personal growth, fostering a positive and proactive approach to their healthcare.
One notable advancement in CLL treatment is the growing array of therapeutic options that extend beyond conventional chemotherapy. BCL-2 inhibitors, such as VENCLEXTA, represent a promising alternative by targeting specific proteins that promote cancer growth. Gonzalez encourages patients to stay informed about their treatment choices, including the chemo-free combination of VENCLEXTA with GAZYVA, which can empower them to take an active role in their health journey.
While VENCLEXTA presents potential benefits, it is crucial to be aware of the serious risks it may pose, such as tumor lysis syndrome. Patients are advised to discuss their medical history and any concerns with their healthcare providers before initiating treatment. By remaining informed and engaged in their healthcare, patients facing CLL can navigate their journey with greater knowledge and confidence.
